Manu Ohri - Jul 15, 2022 Form 4 Insider Report for GT Biopharma, Inc. (GTBP)

Role
CFO & Secretary
Signature
/s/ Manu Ohri
Stock symbol
GTBP
Transactions as of
Jul 15, 2022
Transactions value $
$0
Form type
4
Date filed
7/19/2022, 09:44 PM
Previous filing
Feb 18, 2022
Next filing
Feb 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTBP Common Stock Award $0 +100K $0.00 100K Jul 15, 2022 Direct
transaction GTBP Common Stock Other $0 -100K -100% $0.00* 0 Jul 15, 2022 Direct F1
transaction GTBP Common Stock Other $0 +100K $0.00 100K Jul 15, 2022 By Anarjay Concepts, Inc. F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTBP Option to purchase Common Stock Award $0 +200K $0.00 200K Jul 15, 2022 Common Stock 200K $2.48 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person transferred the shares without consideration to Anarjay Concepts, Inc., a corporation wholly-owned by the reporting person.
F2 66,666 shares on the date of grant, and 66,667 shares on each February 14, 2023 and 2024.